LISAMARIE LEVASSEUR: Open Payments
NPI 1437877727 · ELIZABETHTON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 8 payments from 5 companies in 2025. Trend: 2023 $179 · 2024 $144 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $62 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 1 | $33 |
| Axsome Therapeutics, Inc. | 2 | $28 |
| Dexcom, Inc. | 1 | $23 |
Products named: CAPLYTA, REXULTI, HETLIOZ, Auvelity, Dexcom G6 Transmitter.
Industry payments across TN — which companies pay providers there.
